0001209191-20-013034.txt : 20200226
0001209191-20-013034.hdr.sgml : 20200226
20200226163628
ACCESSION NUMBER: 0001209191-20-013034
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200224
FILED AS OF DATE: 20200226
DATE AS OF CHANGE: 20200226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sachdev Amit
CENTRAL INDEX KEY: 0001406338
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 20656317
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-24
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001406338
Sachdev Amit
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, Chief Patient Officer
Common Stock
2020-02-24
4
F
0
3156
239.23
D
36291
D
Common Stock
2020-02-25
4
S
0
953
230.00
D
35338
D
Common Stock
2020-02-25
4
S
0
270
230.98
D
35068
D
Common Stock
2020-02-25
4
S
0
450
232.62
D
34618
D
Common Stock
2020-02-25
4
S
0
90
233.18
D
34528
D
Common Stock
2020-02-25
4
S
0
533
234.56
D
33995
D
Common Stock
2020-02-25
4
S
0
360
235.75
D
33635
D
Common Stock
2020-02-25
4
S
0
180
236.63
D
33455
D
Common Stock
2020-02-25
4
S
0
540
238.33
D
32915
D
Common Stock
16190
I
Held in Trust
Common Stock
882
I
401(k)
Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $230.00 (range $229.52 to $230.31).
Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $230.98 (range $230.57 to $231.26).
Open market sales reported on this line occurred at a weighted average price of $232.62 (range $232.06 to $233.05).
Open market sales reported on this line occurred at a weighted average price of $234.56 (range $234.27 to $234.66).
Open market sales reported on this line occurred at a weighted average price of $235.75 (range $235.63 to $235.82).
Open market sales reported on this line occurred at a weighted average price of $238.33 (range $238.16 to $238.54).
/s/ Omar White, Attorney-in-Fact
2020-02-26